Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 27 minutes ago
Back to Filings
FORM 4

Insider Trading - June 3, 2025

Filed June 3, 2025
·
Transacted May 30, 2025
·
0000950170-25-081285

COO Klein sold 46,703 shares (~$1.24M) via sell-to-cover + 10b5-1 plan.

Brief

Frank Klein, Chief Operations Officer of Rocket Lab USA Inc., sold 44,885 shares on May 30, 2025, as sell-to-cover for RSU vesting taxes, and 1,818 shares on June 2, 2025, pursuant to a Rule 10b5-1 trading plan adopted in December 2024. Total value approximately $1.24 million at weighted average prices around $26.60. Neutral signal due to automatic, non-discretionary nature.

Detailed Brief

The Form 4 filed on June 3, 2025, reports two open-market sales by Frank Klein, Chief Operations Officer: 44,885 shares sold on May 30, 2025, at a weighted average price of $26.6589 (range $26.05-$27.14) as automatic sell-to-cover to cover tax withholding on vesting restricted stock units, reducing direct holdings to 1,370,190 shares; followed by 1,818 shares sold on June 2, 2025, at $26.5087 (range $26.02-$26.69) under a pre-existing Rule 10b5-1 plan established December 13, 2024, leaving 1,368,372 direct shares. No derivative transactions reported. The 10b5-1 checkbox is marked, confirming planned trading. No prior pattern context provided in filing; these are routine for executives with equity compensation. Prices near recent highs for RKLB (contextual 52-week range not specified but ~$26 aligns with momentum post-earnings).

Key Telemetry

  • Sold 46,703 shares (3.4% of ~1.37M prior direct holdings), retaining 1,368,372 direct shares.
  • Sell-to-cover automatic for RSU taxes; additional sale via 10b5-1 plan (adopted Dec 2024)—standard non-discretionary.
  • Executed at ~$26.60 avg, near recent price highs amid positive momentum.
  • No cluster selling or discretionary elements; first reported trades in recent window.

Impact Vector

These routine, automatic sales via sell-to-cover for taxes and pre-scheduled 10b5-1 plan signal neutral insider confidence, reflecting standard equity compensation management rather than opportunistic selling. No evidence of reduced conviction in RKLB.

Related Disclosures for This Period

Search
Search across missions, customers, news, and SEC filings